BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao D, Liu L, Liu X, Zhang J, Yin Y, Luan L, Jiang D, Yang X, Li L, Xiong H, Xing D, Zheng Q, Xia N, Tao Y, Li S, Huang H. A potent synthetic nanobody with broad-spectrum activity neutralizes SARS-CoV-2 virus and the Omicron variant BA.1 through a unique binding mode. J Nanobiotechnol 2022;20. [DOI: 10.1186/s12951-022-01619-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Wang W, Hu Y, Li B, Wang H, Shen J. Applications of nanobodies in the prevention, detection, and treatment of the evolving SARS-CoV-2. Biochem Pharmacol 2023;208:115401. [PMID: 36592707 DOI: 10.1016/j.bcp.2022.115401] [Reference Citation Analysis]
2 Antoine D, Mohammadi M, Mcdermott CE, Walsh E, Johnson PA, Wawrousek KE, Wall JG. Isolation of SARS-CoV-2-blocking recombinant antibody fragments and characterisation of their binding to variant spike proteins. Front Nanotechnol 2022;4. [DOI: 10.3389/fnano.2022.1028186] [Reference Citation Analysis]